ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

TOBRATHICS

Product Packing: 10 ML

Product Composition: Tobramycin 0.3% eye drop

Product Price: MRP : 125

TOBRATHICS

Tobramycin 0.3% Eye Drop | DROP 10 ML

TOBRATHICS is an ophthalmic drop containing Tobramycin 0.3%. Tobramycin is an aminoglycoside antibacterial used for selected bacterial eye infections caused by susceptible organisms. It should be used only according to the current approved product label and healthcare professional guidance.

Tobramycin binds to the bacterial 30S ribosomal subunit and interferes with protein synthesis, producing antibacterial activity against susceptible organisms. Appropriate diagnosis and antimicrobial stewardship are important because unnecessary or prolonged antibacterial use can encourage resistant or non-susceptible organisms.

Composition

Each approved measured quantity contains:

·         Tobramycin - 0.3%

·         Ophthalmic vehicle / excipients - q.s.

·         Exact Tobramycin salt equivalence, preservative system, buffering agents, sterile specifications and complete excipient details must be verified from the current approved product label.

Dosage form: Eye Drop

Pack size: 10 ml

Uses of TOBRATHICS

TOBRATHICS may be prescribed for selected external bacterial infections of the eye and its adnexa caused by susceptible organisms, according to the approved indication.

·         Provides antibacterial activity against susceptible bacteria

·         May be used in selected bacterial conjunctival or other superficial ocular infections where Tobramycin is clinically appropriate

·         Treatment should be based on professional assessment of the likely bacterial cause and severity

·         It is not effective against viral or fungal eye infections and should not be used indiscriminately for undiagnosed redness or irritation

Eye pain, marked swelling, significant vision change, trauma, chemical exposure, severe light sensitivity or symptoms that worsen or fail to improve require prompt eye-care assessment.

How TOBRATHICS Works

TOBRATHICS contains an aminoglycoside antibacterial:

Tobramycin: Binds to the bacterial 30S ribosomal subunit, disrupting protein synthesis and contributing to bacterial cell death in susceptible organisms.

Its antibacterial spectrum and clinical effectiveness depend on the susceptibility of the infecting organism.

Topical ophthalmic administration delivers the antibacterial locally to the ocular surface, although some systemic absorption may occur.

Clinical response depends on the infection site, organism susceptibility, dose, frequency, treatment duration and individual patient factors.

Antimicrobial stewardship is important: use should be limited to appropriate bacterial indications and the prescribed duration.

 

Dosage and Direction for Use

Use TOBRATHICS strictly according to the current approved product label and healthcare professional's prescription. Dose, frequency and treatment duration depend on the infection and must not be inferred from the concentration alone.

Wash hands before use. Avoid touching the dropper tip to the eye, eyelids, fingers or other surfaces to reduce contamination risk.

If other ophthalmic medicines are prescribed, follow professional or approved-label instructions regarding spacing and order of administration.

Complete the prescribed antibacterial course unless a healthcare professional advises otherwise. Do not extend treatment beyond the recommended duration without reassessment.

Possible Side Effects

Possible adverse effects may include:

·         Temporary burning, stinging, irritation or discomfort after instillation

·         Itching, eyelid swelling or conjunctival redness may occur in some patients

·         Hypersensitivity to Tobramycin or another aminoglycoside is possible

·         Prolonged use may result in overgrowth of non-susceptible organisms, including fungi, and may require reassessment

·         Stop use and seek prompt professional advice for severe pain, marked swelling, significant vision changes, severe hypersensitivity or worsening infection.

Any persistent or troublesome adverse effect should be discussed with a healthcare professional.

Precautions and Contraindications

·         Avoid use in patients with known hypersensitivity to Tobramycin, other aminoglycosides or any formulation excipient.

·         Use only for bacterial eye infections where Tobramycin is appropriate; viral, fungal and non-infectious causes of red eye require different management.

·         Prolonged use can promote overgrowth of non-susceptible organisms and should not continue without clinical reassessment.

·         Cross-sensitivity among aminoglycoside antibiotics may occur in susceptible individuals.

·         Contact-lens use during an active eye infection should follow professional advice and the approved product label; preservative-containing formulations may have additional lens-related instructions.

·         Pregnancy, breastfeeding, pediatric use, recent eye surgery or significant ocular disease require individualized professional guidance.

·         Check the exact preservative system, salt equivalence, excipients, storage conditions and discard-after-opening instructions on the approved label.

·         Keep out of reach of children and do not share the eye-drop container with another person.

·         Drug Interaction Considerations

·         Systemic exposure from ophthalmic Tobramycin is usually limited, but concurrent use of other aminoglycosides or medicines with nephrotoxic, ototoxic or neuromuscular-blocking potential should be reviewed where clinically relevant. Other eye medicines may require dose spacing.

·         Tell the healthcare professional about other ophthalmic medicines and systemic antibiotics being used before treatment.

Business Growth Opportunity with TOBRATHICS

TOBRATHICS offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Tobramycin 0.3% ophthalmic antibacterial drop in a convenient 10 ml pack to an appropriately licensed eye-care portfolio.

Promotion must remain strictly consistent with the approved ophthalmic route, prescription status, indications, warnings, antimicrobial-stewardship principles, permitted claims and applicable regulations.

Key Business Advantages

·         Tobramycin 0.3% ophthalmic formulation

·         Aminoglycoside antibacterial eye-drop product concept

·         Sterile ophthalmic drop dosage form

·         Convenient 10 ml pack

·         Suitable addition to an appropriately licensed eye-care portfolio subject to approved indications

·         Opportunity for ethical, prescription-focused promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for TOBRATHICS

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for TOBRATHICS in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids consistent with approved claims

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for TOBRATHICS and other quality-focused healthcare products.

Third-Party Manufacturing Support for Tobramycin 0.3% Eye Drops

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to TOBRATHICS under their own brand, subject to applicable drug licensing, regulatory and sterile ophthalmic-manufacturing requirements.

Our third-party manufacturing support may include:

·         Approved formulation, preservative system and 10 ml pack configuration support, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed sterile facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed sterile ophthalmic portfolio.

Frequently Asked Questions About TOBRATHICS

1. What is TOBRATHICS?

TOBRATHICS is a 10 ml eye-drop formulation containing Tobramycin 0.3% according to the supplied product brief.

2. What does Tobramycin do?

Tobramycin is an aminoglycoside antibacterial that interferes with bacterial protein synthesis and acts against susceptible bacteria.

3. What type of condition is TOBRATHICS intended for?

It may be prescribed for selected bacterial eye infections caused by susceptible organisms according to the approved indication and professional assessment.

4. Can TOBRATHICS be used for any red eye?

No. Redness can have bacterial, viral, allergic, inflammatory, traumatic or other causes. Tobramycin should be used only when an appropriate bacterial indication is established.

5. Can prolonged use cause problems?

Yes. Prolonged or unnecessary antibacterial use may encourage non-susceptible organisms, including fungi, and can increase the risk of sensitization.

6. How should TOBRATHICS be used?

Use the dose, frequency and duration stated on the approved label or prescribed by a healthcare professional. Avoid touching the dropper tip to the eye or other surfaces.

7. Is a PCD Pharma Franchise available for TOBRATHICS?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Tobramycin 0.3% eye drop may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing, sterile ophthalmic-manufacturing and regulatory requirements.

Disclaimer

TOBRATHICS product information in this document is for general professional and business information. The supplied product brief states Tobramycin 0.3% eye drop, Drop 10 ML. Exact Tobramycin salt equivalence, approved indications, dosage/frequency, age range, prescription/regulatory status, contraindications, warnings, interactions, preservative/excipient system, sterile specifications, contact-lens instructions, storage and discard-after-opening requirements must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Antibacterial use should follow antimicrobial-stewardship principles. Eye pain, marked redness, significant vision changes, trauma or worsening symptoms require appropriate eye-care assessment. This document is not a substitute for professional medical advice.

Contact